摘要
目的研究急性期脑梗死静脉溶栓术后脑水肿给予托拉塞米及甘露醇治疗的效果及患者神经功能和生活质量的改善情况。方法本研究于2017年1月至2019年12月纳入研究对象,均为收治于我院的急性期脑梗死患者,共110例。研究对象均有静脉溶栓术后脑水肿症状。根据随机平均的研究分配原则,分为A组和B组。A组给予每次甘露醇治疗,B组在给予甘露醇治疗基础上给予托拉塞米治疗。治疗时间为1周。结果治疗后对两组治疗效果予以判定,两组对比,结果差异显著P<0.05。治疗后对两组NIHSS评分予以评定,两组对比,结果差异显著P<0.05。治疗后对两组SF-36评分予以评定,两组对比,结果差异显著P<0.05。结论急性期脑梗死静脉溶栓术后脑水肿给予托拉塞米及甘露醇在提高患者治疗效果、神经功能和生活质量方面应用价值明显。
Objective to study effect of torsemide and mannitol on cerebral edema after intravenous thrombolysis in acute cerebral infarction.Methods We chose 110 acute cerebral infarction patients with cerebral edema symptoms after intravenous thrombolysis admitted to our hospital from January 2017 to December 2019.According to random average research principle,divided them into group A and B.Group A was treated with mannitol,and group B with torsemide on the basis of mannitol treatment,with treatment time of 1 week.Results after treatment,treatment effect comparison between two groups showed P>0.05.After treatment,evaluated NIHSS scores of two groups,comparison showed P<0.05.After treatment,evaluated SF-36 scores of two groups,comparison showed P<0.05.Conclusion The treatment with torsemide and mannitol can achieve obvious application value in improving therapeutic effect,neurological function and life quality of patients with cerebral edema after intravenous thrombolysis of acute cerebral infarction.
作者
董宁
DONG Ning(Department of Neurology,Jilin Fourth People's Hospital,Changchun,Jilin,130021)
出处
《智慧健康》
2021年第3期176-178,共3页
Smart Healthcare
关键词
急性期
脑梗死
静脉溶栓
术后脑水肿
托拉塞米
甘露醇
Acute phase
Cerebral infarction
Intravenous thrombolysis
Postoperative cerebral edema
torasemide
Mannitol
